CTOs on the Move

Medicine in Motion

www.medmotion.org

 
Medicine in Motion (MM) is a 501(c)(3) nonprofit organization composed of a diverse group of healthcare providers whose mission is to address medical burnout through fitness, interdisciplinary community building, and philanthropy.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Nutrition Management Services Company

Nutrition Management Services Company is a Kimberton, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Community Health Net Medical

Community Health Net offers a range of healthcare services for newborn through geriatric patients.

Ohana Pacific

Ohana Pacific Health is a locally owned & operated health care management company in Hawaii. We treat everyone and each other like family.

Radiant Pain Relief Centres

Our mission is to change people’s lives by reducing pain and offering services and support to enhance wellness, vitality and prosperity. Radiant Health Management owns and runs progressive, profitable treatment centers that offer cutting-edge therapies and services that improve people’s lives by reducing pain and restoring hope and function. Our Radiant Pain Relief Centres offer a highly refined and patient centered care model, built around an exclusive FDA-cleared pain treatment technology that create significant and lasting pain relief without drugs, needles or surgery.

Nanoscope Therapeutics

Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight to the millions of blind individuals suffering from retinal degenerative disease, for which no cure exists. Nanoscope is focused on proprietary ambient light-activated optogenetic therapy to restore vision in people suffering from various inherited retinal degenerative diseases including Retinitis Pigmentosa, Stargardt, and dry AMD. Genetic retinal degenerative diseases cause vision loss as cells of the retina gradually become dysfunctional. Nanoscope`s proprietary gene therapies correct the condition by delivering light-sensitive molecules, called Multi-Characteristic Opsins (MCO), into retinal cells.